Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test

European Journal of Pharmacology

Volumn 333, Issue 2-3, 1997, Pages 129-134

  Aura, Juhana ^a   Sirviö, Jouni ^a   Riekkinen Jr , Paavo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

correct choice; Alzheimer's disease; Delay dependent and independent; Methoctramine; Muscarinic M1 receptor; Muscarinic M2 receptor; Pirenzepine; Scopolamine

Indexed keywords

METHOCTRAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; DIAMINES; INJECTIONS, INTRAVENTRICULAR; MALE; MEMORY; MOTOR ACTIVITY; MUSCARINIC ANTAGONISTS; PARASYMPATHOLYTICS; PIRENZEPINE; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; SCOPOLAMINE;

EID: 0030963834     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01134-5     Document Type: Article

References (28)

1. 1 cholinergic agonist, AF102B. Pharmacol. Biochem. Behav. 36:1990;89-95.
2. 1 agonist improves cognitive performance in rats. Pharmacol. Biochem. Behav. 51:1995;667-674.
3. Cortes R., Palacios J.M. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies. Brain Res. 362:1986;227-238.
4. Cortes R., Probst A., Tobler H.J., Palacios J.M. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies. Brain Res. 362:1986;239-253.
5. Cortes R., Probst A., Palacios J.M. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: Forebrain. Neuroscience. 20:1987;65-107.
6. Dunnett S.B. Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacol. Berl. 87:1985;357-363.
7. Dunnett S.B., Wareham A.T., Torres E.M. Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats. Neuroreport. 1:1990;61-64.
8. 1 muscarinic antagonist pirenzepine. Psychopharmacol. Berl. 93:1987;470-476.
9. Hammer R., Berrie C.P., Birdsall N.J., Burgen A.S., Hulme E.C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 283:1980;90-92.
10. Herremans A.H., Hijzen T.H., Welborn P.F., Olivier B., Slangen J.L. Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat. Brain Res. 711:1996;102-111.
11. Hunter A.J., Roberts F.F. The effect of pirenzepine on spatial learning in the Morris Water Maze. Pharmacol. Biochem. Behav. 30:1988;519-523.
12. Jäkälä P., Sirviö J., Jolkkonen J., Riekkinen P. Jr., Acsady L., Riekkinen P. The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task. Behav. Brain Res. 51:1992;29-40.
13. Levey A.I., Kitt C.A., Simonds W.F., Price D.L., Brann M.R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 11:1991;3218-3226.
14. Melchiorre C., Quaglia W., Picchio M.T., Giardina D., Brasili L., Angeli P. Structure-activity relationships among methoctramine-related polymethylene tetraamines. Chain-length and substituent effects on M-2 muscarinic receptor blocking activity. J. Med. Chem. 32:1989;79-84.
15. 2 subtypes of muscarinic acetylcholine receptors in the monkey brain. Jpn. J. Pharmacol. 51:1989;247-255.
16. Moore H., Dudchenko P., Bruno J.P., Sarter M. Toward modeling age-related changes of attentional abilities in rats: Simple and choice reaction time tasks and vigilance. Neurobiol. Aging. 13:1992;759-772.
17. 1 muscarinic receptors impairs working memory performance of rats. Brain Res. 650:1994;260-266.
18. Packard M.G., Regenold W., Quirion R., White N.M. Post-training injection of the acetylcholine M2 receptor antagonist AF-DX116 improves memory. Brain Res. 524:1990;72-76.
19. 2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats. Brain Res. 686:1995;37-43.
20. Pitkänen M., Sirviö J., MacDonald E., Ekonsalo T., Riekkinen P. Sr. The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats. J. Neural Transm. Parkinson's Dis. Dementia Sect. 9:1995;133-144.
21. Pontecorvo M.J., Clissold D.B., White M.F., Ferkany J.W. N-methyl-D-aspartate antagonists and working memory performance: Comparison with effects of scopolamine, propranolol, diazepam, and phenylisopropyladenosine. Behav. Neurosci. 105:1991;521-535.
22. Quirion R., Wilson A., Rowe W., Aubert I., Richard J., Doods H., Parent A., White N., Meaney N., Meaney M.J. Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired. J. Neurosci. 15:1995;1455-1462.
23. Sirviö J., Lukkarinen K., Riekkinen P. Jr., Koivisto E., Virtanen R., Pennanen A., Valjakka A., Riekkinen P. Sr. The effects of atipamezole, an alpha-2 antagonist, on the performance of young and aged rats in the delayed nonmatching to position task. Pharmacol. Biochem. Behav. 39:1991;1015-1019.
24. Steckler T., Keith A.B., Wiley R.G., Sahgal A. Cholinergic lesions by 192 IgG-saporin and short-term recognition memory: Role of the septohippocampal projection. Neuroscience. 66:1995;101-114.
25. Tonnaer J.A., Ernste B.H., Wester J., Kelder K. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: A comparative autoradiographic study. J. Chem. Neuroanat. 1:1988;95-110.
26. 1 agonist, enhanced spatial learning in C57BL/10 mice with a long duration of action. Brain Res. 597:1992;264-268.
27. Wamsley J.K., Gehlert D.R., Roeske W.R., Yamamura H.I. Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]-QNB and [3H]-pirenzepine. Life Sci. 34:1984;1395-1402.
28. Watson M., Vickroy T.W., Roeske W.R., Yamamura H.I. Functional and biochemical basis for multiple muscarinic acetylcholine receptors. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 9:1985;569-574.